Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Prabotulinum Toxin-A and Onabotulinum Toxin-A for the Treatment of Expression Lines in the Upper Third of the Face.

NCT05840445 is registered in ClinicalTrials.gov with Instituto de Oftalmología Fundación Conde de Valenciana as lead sponsor.

NCT NCT05840445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05840445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Prabotulinum Toxin-A and Onabotulinum Toxin-A for the Treatment of Expression Lines in the Upper Third of the Face.
Lead sponsor
Instituto de Oftalmología Fundación Conde de Valenciana
Phase
Phase 4
Overall status
Completed
Start date
June 15, 2020
Completion date
January 15, 2021
Enrollment
26 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

face, rejuvenation, skin fold